samedan logo
 
 
spacer
home > epc > winter 2008 > keeping cool
PUBLICATIONS
European Pharmaceutical Contractor

Keeping Cool

Geraint Thomas at Laminar Medica highlights the importance of maintaining control of temperature-sensitive drugs in clinical trials, and explains how common obstacles can be overcome with a combination of careful planning and the latest packaging technology

With an increasing number of clinical trials being conducted internationally, maintaining control of the drugs being trialled is more difficult than ever. This is particularly problematic when the drugs are temperature-sensitive as they commonly have to be transported over considerable distances and, potentially, through multiple climate zones. The repercussions of providing inadequate control measures are considerable, at worst risking the safety of volunteers and the success of the trial. For this reason, choosing the right packaging solution for any trial is essential.

OBSTACLES TO MAINTAINING CONTROL

The factors that make maintaining control so difficult are varied. One of the most problematic is the sheer distance that the drugs now have to travel. With the populations where trials have conventionally been carried out now swamped with prescription and off-the-shelf drugs, sponsors and research organisations have to look to more far-flung countries and regions for noncontaminated test candidates. The logistical challenge of safely shipping drugs over the long distances between the organisation’s base station and the location of the trial are considerable, and far greater than those previously encountered.

For instance, maintaining a consistent and acceptable temperature for sensitive drugs over routes where they are subjected to extreme weather conditions and temperatures, often varying considerably over the duration of the journey, can be particularly difficult. Furthermore, the challenge doesn’t end when the drugs reach their destination; many of these regions are typically prone to high temperatures and extreme humidity. In addition to these conditions, the length of the distance involved can itself be a problem, with many temperaturecontrolled solutions unable to offer adequate protection over an extended period of time.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Geraint Thomas graduated from Brunel University in 1996 with a Bachelor of Science degree with first class Honours in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist responsible for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
spacer
Geraint Thomas
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

“PACK DIFFERENT” with EMBALLAGE 2008

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement